Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 3/20/2016 07:30 LifePaths Discussion of “OECD Health Data”  major progress with SHA and indicators  importance of Ministerial endorsement  appreciating.

Published byMeghan Whitehead Modified over 8 years ago

Similar presentations

Presentation on theme: "1 3/20/2016 07:30 LifePaths Discussion of “OECD Health Data”  major progress with SHA and indicators  importance of Ministerial endorsement  appreciating."— Presentation transcript:

1 1 3/20/2016 07:30 LifePaths Discussion of “OECD Health Data”  major progress with SHA and indicators  importance of Ministerial endorsement  appreciating broader determinants of health and “what works” –versus – primacy of costs and “sustainable financing”  caution re over reliance on SNA concepts Michael Wolfson Statistics Canada

2 2 3/20/2016 07:30 LifePaths Hospital and In-patient Curative-rehabilitative Expenditure previous uncertainty

3 3 3/20/2016 07:30 LifePaths Per Capita Health Care Costs over Time by Use (Current $) ($1.3 billion aggregate drop) * (CIHI)

4 4 3/20/2016 07:30 LifePaths Inputs to Health Services (Part 2) Health Expenditure (Input volumes X prices) Utilization of Services (Part 3) Health Status (Part 1) Social Welfare and Individual Utility Non-medical Determinants (Part 8) The Production of Health - Related Welfare The Flow of Health Expenditure Health Expenditure and Financing (Taxes, Insurance, Out-of- Pocket) (Part 4, 5) Health Expenditure (Utilization volumes X prices) A model for looking at data availability in OECD Health Data Budgeting Decisions Purchasing Decisions Demographic (Part 9) & Economic (Part 10) References Overall social protection (Part 6) Pharma Market (Part 7)

5 5 3/20/2016 07:30 LifePaths The Evans and Stoddart “Plumbing Diagram”

6 6 3/20/2016 07:30 LifePaths top quintile

7 7 3/20/2016 07:30 LifePaths One year mortality rate vs. % revascularized within 14 days, AMI patients in health regions with populations over 100,000, 4 provinces, 1995/96 0 5 10 15 20 25 30 051015202530 Adjusted 1 year mortality rate (%) % revascularized within 14 days (Johansen et. al., Stats Can, 2001) better

8 8 3/20/2016 07:30 LifePaths (with virtually no differences in one year survival; but what about differences in health-related QoL?)

9 9 3/20/2016 07:30 LifePaths Changes in Life Expectancy (LE) and Health- Adjusted Life Expectancy (HALE) by Cause Source: Manuel et al, ICES and Health Canada, NPHS HALELE

10 10 3/20/2016 07:30 LifePaths ONS, Atkinson, and Productivity  mandate (from ONS National Statistician):  “To advance methodologies for the measurement of government output and productivity…” (OK)  “in the context of the National Accounts”  BUT: why not pose issue first in general, and then ask whether SNA is an appropriate framework for this, and if not, what would be?  Caution: OECD should be careful about entering this domain

Download ppt "1 3/20/2016 07:30 LifePaths Discussion of “OECD Health Data”  major progress with SHA and indicators  importance of Ministerial endorsement  appreciating."

Similar presentations

Johan Polder, PhD | Professor in Health Eonomics

Johan Polder, PhD | Professor in Health Eonomics
Measurement of Government Output and Productivity for the National Accounts: Interim Report Tony Atkinson.

Measurement of Government Output and Productivity for the National Accounts: Interim Report Tony Atkinson.
1 Paris 6-7 June 2007 2 nd workshop Measuring Education and Health volume output François LEQUILLER, OECD/STD/NAFS Measuring Education and Health volume.

1 Paris 6-7 June nd workshop Measuring Education and Health volume output François LEQUILLER, OECD/STD/NAFS Measuring Education and Health volume.
8/23/2014 9:17 PM OECD Istanbul June 2007 Making Progress in Health and Health Care  how do we know we are making progress?  need to distinguish two.

8/23/2014 9:17 PM OECD Istanbul June 2007 Making Progress in Health and Health Care  how do we know we are making progress?  need to distinguish two.
Ecological Economics Lecture 10 Tiago Domingos Assistant Professor Environment and Energy Section Department of Mechanical Engineering Doctoral Program.

Ecological Economics Lecture 10 Tiago Domingos Assistant Professor Environment and Energy Section Department of Mechanical Engineering Doctoral Program.
1 Performance Measurement Workgroup Meeting 3/17/2014 New All-Payer Model Monitoring Measures.

1 Performance Measurement Workgroup Meeting 3/17/2014 New All-Payer Model Monitoring Measures.
Tamás Evetovits Senior Health Financing Specialist WHO Regional Office for Europe Financial sustainability in the context of economic crisis: sustaining.

Tamás Evetovits Senior Health Financing Specialist WHO Regional Office for Europe Financial sustainability in the context of economic crisis: sustaining.
Overview of Health Care Coverage and Cost Trends in Minnesota Presentation to the State Budget Trends Study Commission April 22, 2008 Julie Sonier Director,

Overview of Health Care Coverage and Cost Trends in Minnesota Presentation to the State Budget Trends Study Commission April 22, 2008 Julie Sonier Director,
Progress, Well-Being and Sustainable Development Results of the ESS Sponsorship Group S June 2012, Paris Walter Radermacher, Eurostat.

Progress, Well-Being and Sustainable Development Results of the ESS Sponsorship Group S June 2012, Paris Walter Radermacher, Eurostat.
1 HEALTH EXPENDITURE TRENDS: WHAT ARE THE KEY ISSUES FOR POLICY- MAKERS? Eva Orosz and David Morgan Organisation for Economic Co-operation and Development.

1 HEALTH EXPENDITURE TRENDS: WHAT ARE THE KEY ISSUES FOR POLICY- MAKERS? Eva Orosz and David Morgan Organisation for Economic Co-operation and Development.
Differences in the availability of medicines used for chronic and acute conditions in developing countries Alexandra Cameron International Conference on.

Differences in the availability of medicines used for chronic and acute conditions in developing countries Alexandra Cameron International Conference on.
1 SUMMARY OF SOCIAL INDICATORS USED BY THE OECD Denis Ward Statistics Directorate OECD.

1 SUMMARY OF SOCIAL INDICATORS USED BY THE OECD Denis Ward Statistics Directorate OECD.
Assessing the impact of a policy on universal coverage on financial risk protection, health care finance, and benefit incidence of the Thai health care.

Assessing the impact of a policy on universal coverage on financial risk protection, health care finance, and benefit incidence of the Thai health care.
6/1/2015 10:13 AM CMA Ottawa October 2007 On Improving Measures of Outputs and Outcomes in Health Care  what do we want to know?  outputs – why bother.

6/1/ :13 AM CMA Ottawa October 2007 On Improving Measures of Outputs and Outcomes in Health Care  what do we want to know?  outputs – why bother.
Setting a Context for Medicare Spending

Setting a Context for Medicare Spending
MACROECONOMICS BY CURTIS, IRVINE, AND BEGG SECOND CANADIAN EDITION MCGRAW-HILL RYERSON, © 2010 Chapter 4 Measuring National Economic Activity and Performance.

MACROECONOMICS BY CURTIS, IRVINE, AND BEGG SECOND CANADIAN EDITION MCGRAW-HILL RYERSON, © 2010 Chapter 4 Measuring National Economic Activity and Performance.
Rankings: What do they matter, what do they measure? Anne McFarlane August 18, 2010.

Rankings: What do they matter, what do they measure? Anne McFarlane August 18, 2010.
Getting out what we put in: how productive is the NHS in England? Adriana Castelli, Mauro Laudicella Andrew Street & Padraic Ward.

Getting out what we put in: how productive is the NHS in England? Adriana Castelli, Mauro Laudicella Andrew Street & Padraic Ward.
The Current Context Ontario Fiscal Policy Rhetoric Vs. Reality.

The Current Context Ontario Fiscal Policy Rhetoric Vs. Reality.
1 New approaches to measuring non-market output in national accounts: Implications for OECD work on Health Accounts Eva Orosz OECD Health Division Joint.

1 New approaches to measuring non-market output in national accounts: Implications for OECD work on Health Accounts Eva Orosz OECD Health Division Joint.

Similar presentations

Ads by Google